+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Considerations for the Use of Human Participants in Vector Biology Research: A Tool for Investigators and Regulators

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          A thorough search of the existing literature has revealed that there are currently no published recommendations or guidelines for the interpretation of US regulations on the use of human participants in vector biology research (VBR). An informal survey of vector biologists has indicated that issues related to human participation in vector research have been largely debated by academic, national, and local Institutional Review Boards (IRBs) in the countries where the research is being conducted, and that interpretations and subsequent requirements made by these IRBs have varied widely. This document is intended to provide investigators and corresponding scientific and ethical review committee members an introduction to VBR methods involving human participation and the legal and ethical framework in which such studies are conducted with a focus on US Federal Regulations. It is also intended to provide a common perspective for guiding researchers, IRB members, and other interested parties ( i.e., public health officials conducting routine entomological surveillance) in the interpretation of human subjects regulations pertaining to VBR.

          Related collections

          Most cited references 46

          • Record: found
          • Abstract: found
          • Article: not found

          Global malaria mortality between 1980 and 2010: a systematic analysis.

          During the past decade, renewed global and national efforts to combat malaria have led to ambitious goals. We aimed to provide an accurate assessment of the levels and time trends in malaria mortality to aid assessment of progress towards these goals and the focusing of future efforts. We systematically collected all available data for malaria mortality for the period 1980-2010, correcting for misclassification bias. We developed a range of predictive models, including ensemble models, to estimate malaria mortality with uncertainty by age, sex, country, and year. We used key predictors of malaria mortality such as Plasmodium falciparum parasite prevalence, first-line antimalarial drug resistance, and vector control. We used out-of-sample predictive validity to select the final model. Global malaria deaths increased from 995,000 (95% uncertainty interval 711,000-1,412,000) in 1980 to a peak of 1,817,000 (1,430,000-2,366,000) in 2004, decreasing to 1,238,000 (929,000-1,685,000) in 2010. In Africa, malaria deaths increased from 493,000 (290,000-747,000) in 1980 to 1,613,000 (1,243,000-2,145,000) in 2004, decreasing by about 30% to 1,133,000 (848,000-1,591,000) in 2010. Outside of Africa, malaria deaths have steadily decreased from 502,000 (322,000-833,000) in 1980 to 104,000 (45,000-191,000) in 2010. We estimated more deaths in individuals aged 5 years or older than has been estimated in previous studies: 435,000 (307,000-658,000) deaths in Africa and 89,000 (33,000-177,000) deaths outside of Africa in 2010. Our findings show that the malaria mortality burden is larger than previously estimated, especially in adults. There has been a rapid decrease in malaria mortality in Africa because of the scaling up of control activities supported by international donors. Donor support, however, needs to be increased if malaria elimination and eradication and broader health and development goals are to be met. The Bill & Melinda Gates Foundation. Copyright © 2012 Elsevier Ltd. All rights reserved.
            • Record: found
            • Abstract: found
            • Article: not found

            Present and future arboviral threats.

            Arthropod-borne viruses (arboviruses) are important causes of human disease nearly worldwide. All arboviruses circulate among wild animals, and many cause disease after spillover transmission to humans and agriculturally important domestic animals that are incidental or dead-end hosts. Viruses such as dengue (DENV) and chikungunya (CHIKV) that have lost the requirement for enzootic amplification now produce extensive epidemics in tropical urban centers. Many arboviruses recently have increased in importance as human and veterinary pathogens using a variety of mechanisms. Beginning in 1999, West Nile virus (WNV) underwent a dramatic geographic expansion into the Americas. High amplification associated with avian virulence coupled with adaptation for replication at higher temperatures in mosquito vectors, has caused the largest epidemic of arboviral encephalitis ever reported in the Americas. Japanese encephalitis virus (JEV), the most frequent arboviral cause of encephalitis worldwide, has spread throughout most of Asia and as far south as Australia from its putative origin in Indonesia and Malaysia. JEV has caused major epidemics as it invaded new areas, often enabled by rice culture and amplification in domesticated swine. Rift Valley fever virus (RVFV), another arbovirus that infects humans after amplification in domesticated animals, undergoes epizootic transmission during wet years following droughts. Warming of the Indian Ocean, linked to the El Niño-Southern Oscillation in the Pacific, leads to heavy rainfall in east Africa inundating surface pools and vertically infected mosquito eggs laid during previous seasons. Like WNV, JEV and RVFV could become epizootic and epidemic in the Americas if introduced unintentionally via commerce or intentionally for nefarious purposes. Climate warming also could facilitate the expansion of the distributions of many arboviruses, as documented for bluetongue viruses (BTV), major pathogens of ruminants. BTV, especially BTV-8, invaded Europe after climate warming and enabled the major midge vector to expand is distribution northward into southern Europe, extending the transmission season and vectorial capacity of local midge species. Perhaps the greatest health risk of arboviral emergence comes from extensive tropical urbanization and the colonization of this expanding habitat by the highly anthropophilic (attracted to humans) mosquito, Aedes aegypti. These factors led to the emergence of permanent endemic cycles of urban DENV and CHIKV, as well as seasonal interhuman transmission of yellow fever virus. The recent invasion into the Americas, Europe and Africa by Aedes albopictus, an important CHIKV and secondary DENV vector, could enhance urban transmission of these viruses in tropical as well as temperate regions. The minimal requirements for sustained endemic arbovirus transmission, adequate human viremia and vector competence of Ae. aegypti and/or Ae. albopictus, may be met by two other viruses with the potential to become major human pathogens: Venezuelan equine encephalitis virus, already an important cause of neurological disease in humans and equids throughout the Americas, and Mayaro virus, a close relative of CHIKV that produces a comparably debilitating arthralgic disease in South America. Further research is needed to understand the potential of these and other arboviruses to emerge in the future, invade new geographic areas, and become important public and veterinary health problems. Copyright 2009 Elsevier B.V. All rights reserved.
              • Record: found
              • Abstract: found
              • Article: not found

              Impact of Artemisinin-Based Combination Therapy and Insecticide-Treated Nets on Malaria Burden in Zanzibar

              Introduction The increased malaria-related morbidity and mortality, especially in children under the age of 5 y (“under five”), due to emerging resistance of Plasmodium falciparum to conventional antimalarial drugs calls for immediate actions to “Roll Back Malaria” in sub-Saharan Africa. This need has been clearly recognized in the Millennium Development Goals “to halt and begin to reverse malaria incidence” [1] as well as in the Abuja Declaration objective to halve malaria mortality in Africa by 2010 through implementation of combined control strategies [2]. In the year 2000, the overall treatment failure of chloroquine was found to be 60% in a 14-d efficacy trial; consequently the Zanzibar Ministry of Health and Social Welfare decided in November 2001 to change both first- and second-line treatment guidelines for uncomplicated malaria from chloroquine and sulfadoxine-pyrimethamine to artemisinin-based combination therapies (ACT) [3]. The ACT policy was implemented in September 2003, when Zanzibar became one of the first regions in sub-Saharan Africa to recommend routine use of ACT. This action was followed by strengthened vector control, culminating in a nation-wide distribution campaign of long-lasting insecticidal nets (LLINs) from early 2006. Both ACT and vector control measures have independently proven to be efficacious malaria control strategies. Ecological studies have credited ACT with enhancing treatment efficacy, reducing malaria transmission, and possibly forestalling drug resistance in low-endemicity areas [4,5]. Moreover, specific African trials have indicated that the use of insecticide-treated nets (ITNs) or indoor residual spraying can reduce mortality of children under five in Africa [6–9]. This is, however, to our knowledge the first study to examine the public health impact of wide-scale deployment of ACTs alone and combined with ITNs through the general health structure/channels on malaria indices and general health parameters in an endemic area in sub-Saharan Africa. Methods Study Site The study was conducted in North A District, Zanzibar, situated just off the coast of mainland Tanzania. The district is rural and has a population of about 85,000. Subsistence farming and fishing are the main occupations. Plasmodium falciparum is the predominant malaria species and Anopheles gambiae complex is considered the main vector. Malaria transmission is stable with seasonal peaks related to rainfall in March–May and October–December. Malaria transmission in the district prior to the interventions has been reported to be high, but specific entomological data are not available to allow a precise characterization of malaria transmission intensity. However, during the screening process of a major antimalarial drug trial conducted in 2002–2003, a P. falciparum prevalence exceeding 30% was observed in febrile children under five [10], suggesting that North A District had been a high transmission area prior to ACT implementation in September 2003. North A District has one Primary Health Care Centre, which includes a hospital with inpatient and laboratory services, e.g., blood transfusion and malaria microscopy services. Basic medical treatment services without laboratory support are provided in 12 Primary Health Care Units located in different shehias (the smallest political administrative unit in Zanzibar). Drugs, including conventional and artemisinin monotherapies, are also available in private shops throughout the district. Malaria Control Interventions Figure 1 illustrates time of implementation of the two malaria control interventions. Figure 1 Malaria Interventions, Cross-Sectional Surveys, Monthly Rainfall, and Reported Clinical Malaria Diagnoses in Children under 5 Years of Age in North A District, Zanzibar (A) Start of the implementation of artemisinin-based combination therapy for treatment of uncomplicated malaria in September 2003. (B) Introduction of LLINs in February 2006. Promotion of ITNs started in January 2004; the use of conventional ITNs, however, remained low, until the introduction of LLINs. Outpatient data for 2006 are up to June. First intervention—ACT. A loose combination of artesunate and amodiaquine (AS+AQ; from various suppliers with preapproval from WHO) and a fixed combination of artemether–lumefantrine (Coartem; Novartis, Basel, Switzerland), were implemented as first- and second-line treatment, respectively, for uncomplicated malaria in all public health facilities from September 2003. In a pre-implementation assessment of the new treatment policy, partly conducted in North A District 2002–2003, both AS+AQ and artemether–lumefantrine were highly efficacious with PCR-adjusted cure rates by day 28 above 90% [10]. Quinine remained the drug of choice for severe malaria and sulfadoxine-pyrimethamine for intermittent preventive treatment during pregnancy. From September 2003, chloroquine was withdrawn from all health facilities and replaced by free provision of ACT to all malaria patients. Total treatment courses of AS+AQ dispensed in North A 2004 and 2005 were 34,724 and 12,819, respectively. The supply of ACT has been uninterrupted, with no reports of AS+AQ being out of stock from any public health facility in the district during 2003–2006 (unpublished data). ACTs were purchased with support from African Development Bank and Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). Second intervention—vector control. A policy to distribute conventional ITNs to the most vulnerable groups—children under five and pregnant women—free of charge through antenatal clinics or local shehia leaders was officially launched in 2004. However, ITN coverage and use remained low in North A District 2004 and 2005 due to limited number of ITNs distributed, 4,026 and 1,550, respectively. A mass campaign was therefore initiated early 2006, with distribution of 23,000 LLINs to the two most vulnerable groups in North A. This campaign was supported by GFATM and the US Agency for International Development. Cross-Sectional Surveys Three cross-sectional surveys with the primary objective to determine P. falciparum prevalences were conducted in North A District between 2003 and 2006. A two-stage cluster sample technique was used. First shehias and then the households were randomly selected from the sampling frame obtained from the Office of Chief Government Statistician, Zanzibar. The sampling frame was updated before each survey. The first exploratory survey, conducted in May 2003, included 625 households and provided baseline data prior to ACT and widespread ITN implementation. Sample size calculations for the follow-up surveys conducted in May 2005 and 2006 were based on the proportion of children under five with malaria parasitemia in 2003, about 9%, and an assumed relative error of 20%. The calculated number of households to be included was 490 after adjusting for a design effect of 2. Trained interviewers visited all selected households. Interviews and blood sample collection were initiated upon written consent from head of each household and proxy consent from the mother or guardian of each child. Information was recorded using a structured questionnaire on recent febrile illness, mosquito net use, and care-seeking behavior from each individual present in the household at the time of the survey. We did not replace households in which residents were not present at time of survey, could not be located, or refused to participate. Thick blood films were collected from all consenting participants, stained with 5% Giemsa for 30 min, and examined by experienced microscopists for presence and density of P. falciparum parasites. If fewer than ten parasites were detected per 200 white blood cells, examinations were extended to 500 white blood cells. Blood slides were considered negative if no asexual parasites were found in 200 high-power fields. High-density parasitemia was defined as presence of ≥ 5,000 parasites/μl [11]. Quality control was conducted for all positive slides and 10% of the negative slides [12]. Health Facility Records Malaria-related indicators, i.e., outpatient attendances, hospital admissions and blood transfusions, from all 13 public health facilities in North A District were obtained from the Health Management and Information System (HMIS) records of the Zanzibar Ministry of Health and Social Welfare. The existing HMIS records were about 90% complete for the period 2000–2004. Data were validated and missing information retrieved by retrospective review of source documents from all 13 health facilities. This confirmed the HMIS records and resolved missing or inconsistent data, which increased the completeness to nearly 100%. A database of malaria-related indicators was created on the basis of this retrospective review. Data from 2005 were abstracted on quarterly basis. Vital Statistics Records of vital events, i.e., births and deaths, for the period 1998–2005 were obtained from the District Commissioner's Office (DCO) in North A. Annual crude mortalities of children under five were estimated from these data. Demographic estimates were obtained from Tanzania National Population and Housing Census 2002. Rainfall Complete records of monthly rainfall during 1999–2005 were obtained from official registers of the Tanzania Metrological Agency of the Ministry of Communications and Transport. On Unguja island, rainfall is centrally measured in one weather station, situated 26 km (radially) from North A District. The mean annual rainfalls recorded in 2003, 2004, 2005, and 2006 were 702, 1,934, 1,231, and 1,214 mm, respectively. The corresponding mean seasonal rainfall (March–May) between 2003 and 2006 was 285, 786, 890, and 613 mm, respectively. During the post-ACT intervention period (2004–2006) the mean annual and seasonal rainfall was 8%–12% lower than the pre-ACT intervention period (2000–2002). However, the only year with a marked reduction in the mean annual and seasonal rainfalls was the year 2003 with two- to three-fold lower rainfall, as compared to both the preceding and subsequent 3 y. Data Processing and Analysis Data were entered and validated using Microsoft Access and Excel. Statistical analyses for cross-sectional surveys, health facility records, vital statistics, and rainfall data were performed using Stata version 8. Analysis for the surveys was corrected for multi-stage sampling errors using the Rao-Scott second order correction [13]. A logistic regression model with robust standard errors (robust cluster) was used to adjust for the effect of age, sex, sleeping under a mosquito-net, and asset index on asexual P. falciparum prevalence and gametocyte carriage across the study years. Households were the primary sampling units in the surveys and were defined as clusters. Wald test was used to assess the fit of the model and interactions between covariates incorporated in the model. Odds ratios were adjusted for the complex sampling design and covariates listed above. Pearson correlation coefficients were calculated to assess the linear relationships between monthly rainfall and outpatient malaria diagnosis, and malaria-attributed deaths. Ethical Approval Protocols for the household surveys were reviewed and approved by the Medical Research Coordinating Committee of the Tanzanian Commission on Science and Technology, the Zanzibar Health Research Council and the institutional review board of US Centers for Disease Control and Prevention. Results Cross-Sectional Surveys The timings of the cross-sectional surveys in relation to start of each malaria control intervention and seasonal rainfalls are presented in Figure 1. The number of households enrolled and participant characteristics in the respective surveys are shown in Table 1. Over 95% of all participants agreed to both answer questionnaires and provide blood samples in the respective surveys. Table 1 Number of Households Surveyed and Characteristics of Survey Participants The parasite prevalences and odds ratios (ORs) of asexual P. falciparum parasitemia and gametocyte carriage at the time of cross-sectional surveys are shown in Table 2. Between 2003 and 2005 the parasite prevalence was reduced by about 50% in children under five. A further 10-fold decrease in P. falciparum prevalence was observed between 2005 and 2006, following mass distribution of LLINs specifically targeting this age group. Concomitant reductions of parasite prevalence were observed in children over the age of 5 y, although only by about 3-fold, between 2005 and 2006 (OR 0.41, 95% confidence interval [CI] 0.13–1.21), p = 0.08). Table 2 Parasite Prevalence and ORs of P. falciparum Asexual Parasitemia and Gametocytemia in Children 0–14 Years of Age in North A District, Zanzibar, in May 2003, 2005, and 2006 High-density parasitemia (≥5,000/μl) was found in 14 (2.7%) and 2 (0.6%) children under five in 2003 and 2005, respectively. No child carried high-density parasitemia in 2006. Reported fever within 14 d prior to the survey was similar in 2003 and 2006 among children under five (2003, 13% [95% CI 11–17]; 2006, 12% [95% CI 9–16]), whereas care-seeking at public health facilities by recently febrile children under five increased significantly (2003 was reference year; 2005, OR 3.91 [95% CI 0.85–17.9]; 2006, OR 5.5 [95% CI 2.3–13.3]; p-value for trend < 0.001). The proportions of children under five sleeping under effective ITNs were below 10% in both 2003 and 2005 (Table 1), whereas in 2006, 90% were reported sleeping under an LLIN on the night before survey. Health Facility Surveillance All reported clinical outpatient malaria diagnoses in North A District between January 1999 and June 2006 among children under five are shown by month in Figure 1 and by year in Table 3. Between 2002 and 2005 the total number of out-patient malaria diagnoses decreased by 77%. The annual incidences of malaria diagnoses standardized per 1,000 children under five in North A District were 843, 786, and 233 in 2003, 2004, and 2005, respectively. The total number of children under five attending public health facilities for any cause during 1999 and 2005 remained relatively constant, ranging from 31,069 to 39,374 annually. Up to 2003 malaria accounted for about 50% of all outpatient diagnoses in this age group, whereas in 2005 this proportion had decreased to 13%. Table 3 Outpatient Malaria Diagnoses, Hospital Admissions, Blood Transfusions, and Malaria-Attributed Deaths in North A District, Zanzibar, between 2000 and 2005 Malaria-related hospital admissions, non-malaria admissions, and blood transfusions in children under five between 2000 and 2005 are also shown in Table 3. From 2002 to 2005, malaria-related admissions, blood transfusions, and malaria-attributed mortality decreased by 77%, 67%, and 75%, respectively. Crude Mortality Data A total of 23,200 live births and 1,032 deaths in children under five (49% females) were registered between January 1998 and December 2005. The annual mortality figures for children under five, children (1–4 y), and infants (0–1 y) are shown in Table 4. Between 2002 and 2005, crude under five, infant, and child mortality decreased by 52%, 33%, and 71%, respectively. Table 4 Mortality of Children under 5 Years of Age in North A District, Zanzibar between 1998 and 2005 Relationships between Rainfall and Malaria Diagnosis and Deaths In the pre-ACT intervention period (2000–2002), significant positive correlations were found between monthly rainfall and both outpatient malaria diagnoses (Pearson correlation coefficient [r p] = 0.59, p < 0.001) and malaria-attributed deaths (r p = 0.75, p < 0.001), when data were adjusted to allow for a 1-mo lag between rainfall and malaria diagnoses and deaths. However, in the post-ACT intervention period (2003–2005), no significant correlations were found between monthly rainfall and outpatient malaria diagnosis (r p = −0.05; p = 0.75) or malaria-attributed deaths (rp = 0.23; p = 0.20). Discussion Malaria burden in Zanzibar, as in most parts of sub-Saharan Africa, has remained high and in many areas even increased during the last 10–20 y, a major reason being rapid spread of resistance to commonly used monotherapies against malaria. This problem has necessitated urgent implementation of new and effective control strategies to “Roll Back Malaria.” Two main cornerstones in this effort are the introduction of ACTs for treatment of uncomplicated malaria and the promotion of ITN use. The targets for the implementation of these new strategies have been defined by the UN Millennium Development Goals [1] and the Abuja Declaration [2], to be achieved by the years 2015 and 2010, respectively. Deployment of ACTs The ACTs were dispensed free of charge to all patients in the study area through public health facilities from September 2003 onwards. The ACT implementation and deployment was very rapid, effective, and with high coverage. Monitoring of drug supplies confirmed that ACTs were available throughout the study period in all 13 public health care settings in North A District. This outcome also indicates that estimates were adequate of the needed and thus deployed numbers of ACT treatments in the district. This result was accomplished despite an apparent two-fold increase in care seeking among children under the age of 5 y at public health facilities as observed in the cross-sectional surveys. We believe that the observed shift in treatment-seeking behavior at public facilities may be related to availability of free, effective ACTs. A previous study in Zanzibar showed that people's attitudes towards health seeking at public health facilities (biomedical practices) are negatively influenced by the distribution of ineffective antimalarial drugs [14]. High ACT coverage was rapidly achieved in malaria patients despite availability of other drugs in the private sector. This achievement was probably influenced both by comprehensive information to the public and health care staff and by the strong commitment of the Zanzibar government to rapidly ensure free coverage of the ACTs. Also, in North A District, as well as in Zanzibar generally, the entire population has relatively easy access to public health facilities, which are located within 5 km from any community and are served by good transport links. However, the absence of co-formulation or even of co-blistering of the two compounds in the first-line treatment, artesunate and amodiaquine, may have resulted in some degree of monotherapy with either compound. Mortality Impact Our study provides the first, to our knowledge, observation of a reduction in mortality of children under five following introduction of ACTs solely in a stable malaria-endemic setting. The highly significant reduction of 52% in crude under-five mortality according to vital statistics between 2002 and 2005 also highlights the importance of malaria as a major cause of death among children in malaria-endemic areas. The 71% reduction among children aged 1–4 y indicates that the relative contribution of malaria to crude mortality is particularly important in this age group. Major reductions in crude under-five mortality has also been observed in previous randomized intervention studies with ITNs [6,7] and community-based malaria treatment [15,16], but the reduction rates (between 25% and 40%) have been less pronounced than those in our study in Zanzibar. We believe our findings are valid and represent a true picture of the effects of ACT deployment in North A District, Zanzibar. No other major political, socioeconomic, or health-care change with the potential to halve mortality in children under five occurred in Zanzibar after 2002. This includes Expanded Programme on Immunization coverage, which remained constantly above 80% in the district during 1999–2005. Furthermore, there was no significant change in rainfall that may have contributed to the observed reduction in malaria transmission. Indeed, the only year with reduced rainfall with potential influence on vector capacity occurred before the introduction of ACTs—in 2003. Increased use of ITNs may also represent a potential confounding factor in our study. However, the ITN use was below 10% during 2004 and 2005 as reported and observed during the cross-sectional surveys. A significant improvement in ITN coverage was only achieved in 2006 after the introduction of LLINs (see further below) and only affected the 2006 cross-sectional results. We chose 2002 as reference year in our analyses of health facility surveillance and under-five mortality, because 2002 represents the last complete year before ACT introduction in September 2003. Routinely collected mortality statistics may underestimate the true values. However, such data have been shown to provide valid mortality trends [17,18]. Morbidity Impact A significant reduction was found with regard to hospitalization of malaria patients and incidence of blood transfusions, which may be considered proxy indicators of severe malaria. The reduction of severe malaria showing a similar pattern thus supports the under-five mortality trends. This health impact probably represents effects of improved case management of uncomplicated malaria with ACT, thus preventing the development of severe manifestations of the disease. The decrease in malaria morbidity (and mortality) at health facilities between 2003 and 2005 confirms the therapeutic efficacy of ACT [10], but the reduction in outpatient malaria diagnoses may also reflect some transmission blocking effect of artemisinin derivatives through its gametocytocidal activity. Reduction in transmission potential has been suggested after the introduction of artemisinin derivatives (before vector control) for routine treatment in a low and seasonal malaria transmission setting in Thailand [4]. Data obtained from routine health facility records have inherent potential pitfalls and need to be interpreted cautiously. However, the fact that they all show the same downward trend after improved coverage of malaria prevention and treatment interventions, and with no change in the climatic conditions that are favorable for malaria transmission, supports the plausible conclusion that enhanced malaria control interventions contributed to the observed public health benefits. Deployment of ITNs The deployment of LLINs in early 2006 provided a high coverage, i.e., over 90% reported use in children under five in the cross-sectional survey in May 2006. Importantly, this high mosquito-net use was observed after strong government commitment and after free LLIN distribution to children under five and pregnant women. The most significant decrease in prevalence of asymptomatic parasitemia was achieved in 2006, when LLINs were widely used by the children under five, whereas the major impact on the under-five mortality was achieved earlier with ACT use only. Strengthened vector control and the use of ACT also resulted in marked and sustained malaria control in South Africa [5]. The similar public health benefits observed in North A supports the concomitant use of vector control and ACT for malaria control. However, it should be emphasized that our study captures short-term trends in malaria control in North A, which may be too short to generalize long-term trends in the burden of malaria. Sustained coverage and use of LLINs by vulnerable groups is yet to be demonstrated, especially under declining malaria endemicity and if the free LLIN distribution scheme were to be changed. Conclusions The declining under-five mortality, malaria morbidity, and malaria prevalence observed in our study is the first comprehensive evidence supporting the major public health benefits of ACT and ITNs in a stable endemic malaria transmission setting in sub-Saharan Africa. The findings suggest that ACTs with high coverage of ITN use may potentially even eliminate malaria as a public health problem in highly endemic areas of sub-Saharan Africa. High community uptake of the two interventions is probably required but indeed achievable if, as in our study, they are easily available free of charge. The UN Millennium Development Goals to alleviate malaria as a major public health problem and substantially reduce the under-five mortality in sub-Saharan Africa are thus achievable even in settings with historically intense malaria transmission. The sustainability of these efforts as well as surveillance to prevent resurgence of malaria represent key research and programmatic follow-up issues of malaria control in Africa.

                Author and article information

                Vector Borne Zoonotic Dis
                Vector Borne Zoonotic Dis
                Vector Borne and Zoonotic Diseases
                Mary Ann Liebert, Inc. (140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA )
                01 February 2015
                01 February 2015
                : 15
                : 2
                : 89-102
                [ 1 ]Department of Biological Sciences, Eck Institute for Global Health , University of Notre Dame, Notre Dame, Indiana.
                [ 2 ]Centers for Disease Control and Prevention , Atlanta, Georgia.
                [ 3 ]Public Health and Malaria Control , International SOS, Papua, Indonesia.
                [ 4 ]Centre for Ethical, Social and Cultural Risk, Li Ka Shing Knowledge Institute of St. Michael's Hospital , Toronto, Canada.
                [ 5 ]Dalla Lana School of Public Health and Joint Centre for Bioethics, University of Toronto , Ontario, Canada.
                [ 6 ]Foundation for the National Institutes of Health , Bethesda, Maryland.
                Author notes
                Address correspondence to: Nicole L. Achee, PhD, Research Associate Professor, Eck Institute for Global Health Department of Biological Sciences, 239 Galvin Life Science Center, Notre Dame, IN46556, E-mail: nachee@
                © The Author(s) 2015; Published by Mary Ann Liebert, Inc.

                This Open Access article is distributed under the terms of the Creative Commons License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

                Figures: 5, References: 77, Pages: 14


                Comment on this article